Trial Profile
The effect of the cognitive function and cerebral white matter lesions of pitavastatin in hypercholesterolemic patients with cognitive dysfunction.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 05 Jul 2017 Status changed from not yet recruiting to completed.
- 19 Mar 2014 New trial record